Clinical characteristic of parenteral iron supplementation in hemodialysis patients receiving erythropoietin therapy

Chang Gung Medical Journal

Volumn 23, Issue 10, 2000, Pages 608-613

  Kao, H H ^a   Chen, K S ^a   Tsai, C J ^a   Lee, C C ^a   Chang, H Y ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Erythropoietin; Ferric saccharate; Ferritin; Hemodialysis (HD); Uremia

Indexed keywords

IRON SACCHARATE; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FERRITIN BLOOD LEVEL; HEMATOCRIT; HEMODIALYSIS; HUMAN; INTERMETHOD COMPARISON; IRON DEFICIENCY ANEMIA; IRON THERAPY; KIDNEY FAILURE; MALE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ANEMIA; DRUG ADMINISTRATION SCHEDULE; ERYTHROPOIETIN, RECOMBINANT; FERRIC COMPOUNDS; FERRITINS; HEMATOCRIT; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; IRON; MIDDLE AGED; RENAL DIALYSIS; UREMIA;

EID: 0033710166     PISSN: 02558270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. A comparision of the responses to recombinant human erythropoietin in normal and uremic subjects
2. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin
3. Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis
4. Iron deficiency in maintenance hemodialysis patients. Assessment of diagnosis criteria and of three different iron treatments
5. Iron status of dialysis patients under rhuEPO therapy
6. Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation
7. A randomized controlled study of iron supplementation in patients treated with erythropoietin
8. Iron metabolism under rEPO therapy in patients on maintenance hemodialysis
9. Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin
10. Iron metabolism in patients with the anaemia of end-stage renal disease during treatment with recombinant human erythropoietin
11. Intradialytic oral iron therapy
12. Monitoring of iron requirements in renal patients on erythropoietin
13. Intravenous ferric saccharate as an iron supplement in dialysis patients
14. Iron status in patients receiving erythropoietin for dialysis-associated anemia
15. Iron metabolism in patients with chronic renal failure
16. Regulation of iron absorption in iron loaded subjects with end stage renal disease: Effects of treatment with recombinant human erythropoietin and reduction in iron stores
17. Erythropoietin treatment in haemodialysis patients with iron overload
18. Effect of recombinant human erythropoietin on iron balance in maintenance hemodialysis: Theoretical considerations, clinical experience and consequences
19. Iron management during treatment with recombinant human erythropoietin in chronic renal failure
20. Serum ferritin, hematocrit and mean corpuscular volume in hemodialysis
21. Variations in erythropoiesis and serum ferritin during erythropoietin therapy for anaemia of end stage renal disease
22. Iron overload associated myopathy in patients on maintenance hemodialysis: A histocompatibility linked disorder
23. Hepatic hemosiderosis in maintenance hemodialysis patients
24. Is anaemia during continuous ambulatory peritoneal dialysis really better than during haemodialysis
25. The prevalence and significance of occult blood loss in patients with predialysis advanced chronic renal failure (CRF), or receiving dialytic treatment
26. Clinical use of the total dose intravenous infusion of iron dextran
27. Comparative therapeutic study of TDI and IM injections of iron dextran in anemia
28. NKF-Dialysis Outcomes Quality Initiative clinical practice guidelines for the treatment of anemia of chronic renal failure: Iron support
29. Guide to total dose intravenous iron dextran
30. Iron management in end stage renal disease
31. The role of iron and other factors in patients unresponsive to erythropoietin therapy
32. A randomized trial of three iron dextran infusion methods for anemia in erythro-poietin-treated dialysis patients
33. Safety and efficacy of total dose iron dextran administration in patients on home renal replacement therapies